MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
17.31
+0.06 (0.35%)
Feb 18, 2026, 4:00 PM EST - Market closed
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $755.43 million as of February 18, 2026.
Market Cap
755.43M
Enterprise Value
534.27M
1-Year Change
n/a
Ranking
Category
Stock Price
17.31
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $755.43M, an increase of 7.26%. That is a compound annual growth rate of 25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 752.81M | -1.79% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Arbutus Biopharma | 794.30M |
| Bicara Therapeutics | 783.38M |
| KalVista Pharmaceuticals | 775.89M |
| MiMedx Group | 768.65M |
| Annexon | 757.20M |
| Arvinas | 756.56M |
| Gyre Therapeutics | 756.21M |
| Maravai LifeSciences Holdings | 755.61M |